Nuvalent | Investor Presentation Deck | 52 slides · page 39 of 52
The chart displays patient-level data categorized by dose (15mg to 200mg) and mutation type, highlighting the efficacy of the drug in clearing specific ALK mutations.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 disclaimer 1/1 legend 1/1 title 1/1
Components 5
primary waterfall disclaimer legend headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.